Based on the Phathom Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for Phathom Pharmaceuticals Inc is USD 25.33 over the next 12 months. Phathom Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Phathom Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Phathom Pharmaceuticals Inc’s stock price was USD 18.94. Phathom Pharmaceuticals Inc’s stock price has changed by +8.98% over the past week, +9.80% over the past month and +116.95% over the last year.
No recent analyst target price found for Phathom Pharmaceuticals Inc
No recent average analyst rating found for Phathom Pharmaceuticals Inc
Company Overview Phathom Pharmaceuticals Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Phathom Pharmaceuticals Inc (PHAT)
Loading...
Unadjusted Closing Price for Phathom Pharmaceuticals Inc (PHAT)
Loading...
Share Trading Volume for Phathom Pharmaceuticals Inc Shares
Loading...
Compare Performance of Phathom Pharmaceuticals Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for PHAT
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Phathom Pharmaceuticals Inc (Sector: Biotechnology )
Frequently Asked Questions About Phathom Pharmaceuticals Inc (PHAT) Stock
Based on ratings from 3 analysts Phathom Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 11 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on PHAT's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for PHAT is USD 25.33 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on PHAT's stock to indicate if its overvalued.
The last closing price of PHAT's stock was USD 18.94.
Unfortunately we do not currently have any market capitalization data for PHAT's stock.
Based on targets from 3 analysts, the average taret price for PHAT is projected at USD 25.33 over the next 12 months.
This means that PHAT's stock price may go up by +33.76% over the next 12 months.
We can't find any ETFs which contains Phathom Pharmaceuticals Inc's stock.
Sorry, we do not have any data on the number of employees for Phathom Pharmaceuticals Inc.
Sorry we do not have any infomation available on Phathom Pharmaceuticals Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Phathom Pharmaceuticals Inc (PHAT) Stock
Based on ratings from 3 analysts Phathom Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 11 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on PHAT's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for PHAT is USD 25.33 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on PHAT's stock to indicate if its overvalued.
The last closing price of PHAT's stock was USD 18.94.
Unfortunately we do not currently have any market capitalization data for PHAT's stock.
Based on targets from 3 analysts, the average taret price for PHAT is projected at USD 25.33 over the next 12 months.
This means that PHAT's stock price may go up by +33.76% over the next 12 months.
We can't find any ETFs which contains Phathom Pharmaceuticals Inc's stock.
Sorry, we do not have any data on the number of employees for Phathom Pharmaceuticals Inc.
Sorry we do not have any infomation available on Phathom Pharmaceuticals Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PHAT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
